Introduction
============

Subcellular compartmentalization of mRNAs is a mechanism enabling local synthesis of proteins required for neuronal development and plasticity such as brain-derived neurotrophic factor (BDNF; [@B59]; [@B54]; [@B53]; [@B46]; [@B57]; [@B31]). Although *BDNF* mRNA abundance in dendrites is generally low, dendritic localization is enhanced in response to membrane depolarization ([@B59]) or to BDNF itself ([@B45]). Evidence that *BDNF* mRNA translation can occur in dendrites was provided by studies *ex vivo* using neurosynaptosomes ([@B43]; [@B19]) and *in vitro* in hippocampal neurons ([@B4]; [@B61]; [@B7]). The mechanism underlying *BDNF* mRNA targeting to dendrites is poorly understood, partly because of the complexity of *BDNF* gene regulation (**Figure [1A](#F1){ref-type="fig"}**, upper panel). Transcription of rodent *BDNF* gene produces 11 transcripts, each with a different alternatively spliced 5′ untranslated region (5′ UTR) and the same coding region (CDS; **Figure [1A](#F1){ref-type="fig"}**; [@B1]; [@B42]). These transcripts can exist in two isoforms, either with long (3.2 Kb) or short (0.3 Kb) 3′ UTR (**Figure [1A](#F1){ref-type="fig"}**, bottom panel; [@B1]; [@B42]). There is general consensus that most *BDNF* transcripts are restricted to the soma and proximal dendrites (e.g., exons 1, 4) but selected variants are transported distally (e.g., exons 2, 6) in an activity-dependent manner ([@B4]; [@B9], [@B10]; [@B2]; [@B6]; [@B63]).

![**Inducible targeting of endogenous *BDNF* mRNA in primary hippocampal neurons.** **(A)** Upper panel, illustration of the rat BDNF gene structure with the 5′ UTR exons (light gray) and the coding sequence/3′ UTRs exon (black); bottom panel, a schematic representation of the rat splice variants according to the nomenclature proposed by [@B1]. **(B)** Representative *in situ* hybridization (ISH) on control cultures and after 3 h of 10 mM KCl, 50 ng/mL of NGF, BDNF, NT-3 and NT-4 stimulation; scale bar 10 μm. **(C)** Quantification of *BDNF* mRNA maximum dendritic distance labeling (MDDL) in dendrites of treated neurons normalized to control neurons upon different treatments with or without Trk inhibitor K252a (^∗∗∗^*P* \< 0.001 vs. control, Kruskal--Wallis one way ANOVA on Ranks followed by Dunn's multiple comparison test).](fnmol-08-00062-g001){#F1}

To explain the mechanism of BDNF transcripts' sorting, two alternative models were proposed. The first is a dualistic mechanism by which somatic *BDNF* transcripts express the short 3′ UTR while dendritic transcripts have the long 3′ UTR ([@B4]). However, in rodent brain models, transcripts containing exons 1, 2, 4, and 6 (formerly I, II, III, IV) are expressed with long or short 3′ UTR in a 1:1 ratio and, after kainic acid-induced seizures, transcripts having mainly the short 3′ UTR are detected ([@B56]). Remarkably, following seizures, exons 2 and 6 were detected in distal dendrites ([@B9]; [@B6]). Our alternative model is based on a tripartite combinatorial mechanism in which "selector" signals are located in the 5′ UTR (for dendrite or soma destination), a constitutively active dendritic targeting element (DTE) mediated by Translin in the CDS, and activity-dependent DTEs harbored in both long and short 3′ UTRs ([@B39]; [@B9], [@B10]; [@B2]; [@B7], [@B6]). In support of this model, *BDNF* mRNAs with either 3′ UTRs were shown to be transported in dendrites in response to neural activity ([@B37]; [@B7]). Activity-dependent dendritic targeting of the 3′ UTR short requires the RNA-binding protein (RBP) CPEB-1 ([@B37]) while the targeting mechanism of the 3′ UTR long was not investigated. Here, we investigated the dendritic targeting mechanism of *BDNF* transcripts with long or short 3′ UTR, demonstrating selective induction by BDNF or NT-3, respectively thanks to interactions with distinct sets of RBPs.

Materials and Methods {#s1}
=====================

Chimaeric GFP Constructs
------------------------

Total RNA was extracted from whole rat brain using TriZol^®^ Reagent (Invitrogen). 1 μg of total RNA was reverse-transcribed into cDNA and amplified with specific primer pairs. For details on BDNF CDS-GFP chimera cloning (please see, [@B10]). PCRs were performed with Phusion Hi-Fidelity DNA polymerase (New England BioLabs) using specific primer pairs and PCR conditions (reported in **Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). A direct amplification and cloning in pEGFP-N1 vector (Clontech) was performed for BDNF 3′ UTRshort, 3′ UTRshort-mutELAV-up, 3′ UTRlong, 3′ UTRmid and 3′ UTRend. For 3′ UTRshort-mutCPE and 3′ UTRshort-mutELAV-dw cloning, an assembly strategy was adopted. Briefly a first round of PCR was performed using the primer pairs for CPE and ELAV-dw mutations (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). The second round of PCR was performed using CPE and ELAV-dw mutant fragments obtained in the first round as forward "megaprimers" with 3′ UTRsh reverse primer to obtain mutated full length 3′ UTR short sequences. PCR fragments were then purified (PCR Cleanup kit from Sigma-Aldrich) and digested with XhoI/SacII for BDNF coding sequence or NotI/HpaI for 3′ UTRs mutants. All restriction enzymes were purchased from New England BioLabs. Digested fragments were gel purified (PCR Gene Elute kit from Sigma-Aldrich) and ligated (T5 DNA ligase from New England BioLabs) over night at 16° with properly digested pEGFP-N1 vector.

Protocol for CLIP
-----------------

The CLIP (cross-linking and immunoprecipitation) assay for ELAV was performed as previously described by [@B44] and for FMRP was carried out using brains lysates from wild type (WT) and *Fmr1*-KO mice as described by [@B12]. Radiolabeled riboprobes for BDNF 3′ UTR sequences were obtained by transcribing pBluescript KS containing BDNF 3′ UTR short, 3′ UTR mid, and 3′ UTR end sequences. Oligos and conditions used for BDNF coding sequence Reverse transcriptase-PCR on CLIP are reported in **Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**. PCR oligos and conditions used for Pgk1 and Map1b were previously described by [@B14].

Bioinformatic Analysis
----------------------

Analysis of evolutionary conserved regions in BDNF CDS and 3′ UTRs was performed using phastCons alignment software ([@B52]). The research of putative *cis*-elements for RBPs on rat BDNF 3′ UTR sequence was performed using Bioedit software (<http://www.mbio.ncsu.edu/BioEdit/bioedit.html>). The RNA motifs reported in literature for the cited RBPs were pairwise aligned on the target sequence and at least 80% homology was set as threshold to define a putative *cis*-element.

RNAi Interference
-----------------

RNAi interference (RNAi) "cocktails" against the different RBPs were generated by RNAseIII (Ambion) cleavage of relatively long (∼300 nt) double-stranded RNA. Target regions of mRNA encoding for RBPs were identified by consulting the NCBI data base. To amplify the target regions, oligonucleotidic primers containing the T7 promoter were used to amplify the target regions and produce siRNA following manufacturer instructions. Sequences and protocol are reported in **Supplementary Table [S2](#SM1){ref-type="supplementary-material"}**. In order to evaluate RNAi "cocktails" efficacy and specificity, reverse transcriptase PCR was performed on RNA extracted from primary hippocampal cultures of rat neurons. To amplify the targeted mRNAs we used oligonucleotidic primers containing the same sequence designed for siRNA pools generation. Sequences and protocol are reported in **Supplementary Table [S2](#SM1){ref-type="supplementary-material"}**. For quantification, PCR bands were scanned and quantified by the Quantity One^®^ 4.6.6. software (Bio-Rad, Hercules, CA, USA).

Cell Cultures
-------------

Primary rat and mouse hippocampal neurons were prepared from P0 pups as previously described ([@B59]) with slight modifications. Cells were plated on 2% Matrigel (BD Biosciences) coated coverslips in 24-well plates at a density of 2 × 10^5^ cells per well and cultured for 6 days in neurobasal supplemented with B27 (Invitrogen) and pen/strep in a 5% CO~2~-humidified incubator. The medium was changed every 2 days from the second day in culture onward. PC12 rat pheochromocytoma cells, used to asses RBP siRNAs efficiency and specificity, were cultured in RPMI medium supplemented with 10% FBS, 5% Donor Horse Serum, 2 mM [L]{.smallcaps}-glutamine, 20 mM Hepes and antibiotics (Euroclone) and differentiated in DMEM containing 1% horse serum, 1% Pen-Strep, and 50 ng/ml NGF (Sigma). Cells were transfected with Lipofectamine2000^TM^ (Invitrogen) with 1 μg of plasmid DNA or 19 nM of siRNA mixture (at 6 DIV for neurons or 75% confluency for PC12 cells). Neurons were depolarized as previously described ([@B59]), or treated with different neurotrophins (BDNF, NT-3, NT-4; SIGMA) at a 50 ng/mL concentration in culture medium. After 3 h of depolarization or neurotrophin administration, cells were fixed with PFA 4% for 15' at RT.

Animal Treatment
----------------

Animals were treated according to the institutional guidelines in compliance with the European Council Directive 86/609 and NIH Guide for the Care and Use of Laboratory Animals. Animal experiments on WT and BDNF^lox/lox^ mice were authorized by the Italian Ministero della Salute n. 185/2010-B d.d. 21/10/2010. Two month old male C57/BL6 or BDNF^lox/lox^ mice ([@B20]) were anesthetized with urethane (1 g/kg, i.p.) 30 min prior to i.p. injection of 300 mg/kg pilocarpine or saline. Animals were housed in groups under standard animal room conditions (12:12 h light/dark cycle, ambient temperature 23°C, ad libitum access to food and water).

*In situ* Hybridization and Fluorescent *In situ* Hybridization
---------------------------------------------------------------

*In situ* hybridization (ISH) on brain sections or cultures was performed as previously described ([@B59], [@B60]). Cells were fixed for 15 min at RT in 4% PFA in PBS, washed in PBST, and permeabilized in absolute ethanol for 15 min at -20°C. After rehydration, cells were hybridized with antisense or sense probes for GFP mRNA or *BDNF* CDS. The open reading frame of GFP or BDNF CDS were subcloned into pBluescript or pGEM vectors respectively and DIG- labeled probes were synthesized with the DIG-RNA labeling kit (Roche Diagnostics) using linearized plasmids as templates, according to the manufacturer's instructions. Hybridization was followed by high stringency washes with 0.01x Sodium Saline Citrate buffer containing 0.1% Tween20 (SSCT) at 60°C, then coverslips were incubated with anti-digoxigenin alkaline phosphatase coupled antibody and developed with NBT and BCIP for 40 min at RT. For fluorescent *in situ* hybridization (FISH) after PFA fixation cells were incubated with H~2~O~2~/PBS 0.3% for endogenous peroxydase quenching and then permeabilized with EtOH. After probe hybridization and stringency washes, coversplis were incubated with anti-digoxigenin horse-radish peroxidise conjugated (Roche) diluted 1:300 in blocking solution at RT for 1 h. HRP detection was performed using Tyramide System Amplification kit -- Cyanin 3 coupled (Perkin Elmer) following manufacturer instructions. After three washes in TNT buffer, cells were incubated with the primary antibodies against different RBPs diluted in PBST/FBS 5% (**Supplementary Table [S3](#SM1){ref-type="supplementary-material"}**). Nuclei were stained with Hoechst 33342 and the coverslips were mounted with Mowiol (Sigma). ISH on free-floating, 40 μm coronal sections cut at the level of dorsal hippocampus was performed as previously described ([@B59], [@B60]). After permeabilization, sections were pre-hybridized at 55°C for 1 h followed by an overnight incubation at 55°C with 100 ng/mL BDNF CDS antisense probe. ISH was stained with the fluorescent anti-DIG enhancer set (Roche diagnostics), following manufacturer's instructions. Sections were mounted in anti-fade mounting solution (Invitrogen) and stored at 4°C in dark.

Confocal images of FISH on brain slices were acquired by a Nikon Eclipse C1si confocal system mounted on a Nikon TE-2000U inverted microscope. We used a Plan-Apochromat 20x/0.75(NA) and 60x/1.4(NA) oil-immersion objectives. The resolution used was of 0.2 μm × 0.2 μm × 0.5 μm (XxYxZ) for 20X acquisitions and 0.08 μm × 0.08 μm × 0.25 μm (XxYxZ) for 60X acquisitions. To obtain comparable signals between control and treated conditions, confocal images were acquired keeping the same acquisition settings for laser intensity, pmt amplification, pinhole aperture (33 μm) and pixel dwell (0.48 μs).

Immunohistochemistry
--------------------

Brain-derived neurotrophic factor immunohistochemistry on WT and BDNF^lox/lox^ brain sections were performed on 2% PFA perfused brains cut at 40 μm thick coronal sections, as previously described ([@B58]). Slices were developed through Nickel-enhanced diamminobenzidine (DAB) chromogenic reaction for about 20--30 min at room temperature in dark. All passages, except development, were performed in gentle shaking.

Western Blots
-------------

Cells were collected in lysis buffer and the lysates were centrifuged at 10000 rpm for 15 min at 10°C to remove cellular debris. Protein concentration was determined using Bradford assay. Samples were resolved on 12% SDS-PAGE gels, loading 20 μg of PC12 extracts. Proteins were transferred onto nitrocellulose membrane (Schleicher&Schuell) and stained using the different antibodies (**Supplementary Table [S3](#SM1){ref-type="supplementary-material"}**). Membranes were then washed 3 min × 5 min in 5% non fat milk in PBST and incubated for 1 h at RT with the respective secondary antibody (**Supplementary Table [S3](#SM1){ref-type="supplementary-material"}**) and membrane developed with chemiluminescent substrate (ECL by GE Healthcare). X-ray films were scanned and quantified by the Quantity One^®^ 4.6.6. software (Bio-Rad, Hercules, CA, USA).

Colocalization Analysis
-----------------------

Confocal images were acquired by a Nikon Eclipse C1 confocal microscope mounted on a Nikon TE-2000U inverted microscope using a Plan-Apochromat 60x/1.4 oil-immersion objective. Sequential scanning laser was used to avoid cross talk between different fluorochromes. Only pyramidal neurons with clear dendrites were acquired, with a z-stack thickness of 200 nm (12 stacks). At least 21 neurons from three independent experiments were measured for colocalization analysis. Regions of interest (ROI) had a 10 μm × 5 μm × 2.4 μm size located in the proximal (10 μm far from soma) and distal (at least 60 μm far from soma) compartments of apical dendrites. After ROI selection images were cropped, then background was automatically subtracted using Imaris software (Bitplane). Images were then deconvolved using Huygens software with classical CMLE algorithm. "Coloc" function of Imaris was used to perform colocalization analysis Automatic threshold was applied to each image before Manders coefficients calculation. Images of colocalization between mRNA and RBPs are Z-stack maximum projection of representative dendrite shafts analyzed. The images were post-processed to linearly increase brightness equally in the whole panel for visualization purpose.

Quantitative Imaging Analysis and Statistics of Non-radioactive *In situ* Hybridization
---------------------------------------------------------------------------------------

Non-radioactive ISH was analyzed by viewing stained cultures under bright-field illumination as previously described ([@B59]; [@B10]) with slight modifications. In detail, individual preparations were coded and analyzed in a blind manner with respect to treatments. Bona-fide pyramidal neurons were randomly sampled from each culture and acquired by a Nikon AXM1200 digital camera on a Nikon E800 Microscope with interference contrast-equipped lens (60x magnification) and then analyzed with the image analysis program ImageJ 1.44 (NIH) using the "Straighten" plugin. Dendritic targeting of *BDNF* transcripts in apical dendrites of pyramidal neurons was evaluated as the maximum distance of dendritic labeling (MDDL) measured in μm from the soma using the "Trace" function of the software Image-ProPlus 4.0 (Media Cybernetics). Straightened dendrites were "traced" in a conservative manner, starting from the base of dendrite after soma and up to the point in which *in situ* labeling was clearly distinguishable. At least 150 neurons from four independent experiments were measured for each condition. For both MDDL analysis and semi-quantitative densitometric analysis of BDNF mRNA ISH levels, we used standardized development time of alkaline phosphatase reaction of 40 min at RT. Labeling intensity was measured as a scale of gray levels from 0 = no staining to 255 = saturated black staining, using the software Image-ProPlus 4.0 (Media Cybernetics) as previously described ([@B10]). Background level for each dendrite was determined by evaluation of the mean gray value in the distal portion of apical dendrites of transfected neurons in which *in situ* labeling was not present. Background staining was then substracted from each dendrites before averaging. This procedure produces densitometric data that are expressed in arbitrary units (or gray levels). This densitometric method to quantify ISH does not require signal normalization, as previously validated in ours and other laboratories ([@B4]; [@B10]). Statistical significance among groups was evaluated performing Kruskal--Wallis one-way ANOVA on ranks, followed by a multiple comparison procedure with Dunn's method.

Results
=======

Inducible Dendritic Targeting of Endogenous *BDNF* mRNA
-------------------------------------------------------

We previously showed that neuronal depolarization and BDNF induce dendritic localization of BDNF mRNA *in vitro* ([@B59]; [@B45]), however, it remained undetermined if other neurotrophins can also induce BDNF mRNA localization in dendrites. To investigate the effect of neurotrophins we treated primary rat hippocampal neurons at 6 days *in vitro* (DIV) for 3 h with NGF, BDNF, NT-3, NT-4 (50 ng/ml) or 10 mM KCl. Endogenous *BDNF* mRNA was detected in isolated cultured cells using non-radioactive ISH using a probe targeting the CDS and hence recognizing all the possible *BDNF* transcripts expressed (**Figure [1A](#F1){ref-type="fig"}**). Dendritic targeting of *BDNF* transcripts was evaluated as the MDDL from the soma, normalized to untreated condition. At least 150 neurons from four independent experiments were measured for each condition. KCl treatment induced a 2.83 ± 0.17 fold increase of *BDNF* mRNA targeting with respect to basal culturing conditions (**Figures [1B,C](#F1){ref-type="fig"}**). Stimulation with BDNF and NT-3 induced also a significant fold increase compared to untreated cells (1.59 ± 0.11 and 1.49 ± 0.10, respectively), while NGF and NT-4 did not significantly alter *BDNF* mRNA distribution along dendrites (**Figures [1B,C](#F1){ref-type="fig"}**). Activity of neurotrophins and KCl solution used in these experiments was demonstrated by translocation of *c-fos* in the nuclei (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). Blocking Trk receptors activity with the inhibitor K252a prevented *BDNF* mRNA dendritic translocation after application of BDNF or NT-3 (**Figure [1C](#F1){ref-type="fig"}**). Inhibition of Trk signaling by K252a also depressed KCl-dependent dendritic targeting, suggesting the contribution of neurotrophin signaling during KCl-induced neuronal depolarization, as previously described for BDNF stimulation ([@B45]). These data provide strong evidence that distal dendritic localization of endogenous *BDNF* mRNA can be induced in hippocampal neurons by depolarization, BDNF and NT-3.

Long and Short *BDNF* 3′ UTRs Respond Differently to NT-3 and BDNF
------------------------------------------------------------------

We previously showed that upon treatment with high KCl, the short 3′ UTR BDNF can target the mRNA of a reporter gene to the distal dendrites of cultured neurons ([@B7]). To investigate the role of short and long 3′ UTRs with respect to the stimulation with activity, BDNF or NT-3, primary rat hippocampal neurons were transfected with GFP-3′ UTR short or GFP-3′ UTR long chimeras. Cultures were stimulated for 3 h with 10 mM KCl or 50 ng/ml of each neurotrophin, and neurons were subjected to non-radioactive ISH using a DIG-labeled GFP antisense probe and finally, the MDDL from the soma was measured (**Figure [2](#F2){ref-type="fig"}**). No unspecific staining was detected using GFP sense strand probes (**Figure [2D](#F2){ref-type="fig"}**, middle panel). In resting neurons, the short 3′ UTR was mainly confined in the proximal dendritic compartment (MDDL = 41.56 ± 0.82 μm) similar to GFP mRNA (MDDL = 40.34 ± 1.72 μm; **Figures [2A,B](#F2){ref-type="fig"}**). GFP mRNA localization was not modified by neuronal depolarization (MDDL = 40.36 ± 1.87 μm), whilst GFP-3′ UTR short mRNAs showed a significant translocation in distal dendrites both after high potassium depolarization (MDDL = 80.57 ± 1.94 μm, *P* \< 0.001) or treatment with NT-3 (MDDL = 69.14 ± 1.61 μm, *P* \< 0.001). NGF, BDNF or NT-4 had no effect on GFP-3′ UTR short mRNA localization (**Figures [2A,B](#F2){ref-type="fig"}**). Trk tyrosine kinase inhibitor K252a abolished the GFP-3′ UTR short dendritic localization in response to NT-3 application, in accordance with the results previously seen for endogenous BDNF mRNA (**Figure [2B](#F2){ref-type="fig"}**). Similarly, KCl-induced translocation was significantly impaired, suggesting that a NT3-dependent mechanism plays a substantial role in activity-induced dendritic targeting of short 3′ UTR transcripts (**Figure [2B](#F2){ref-type="fig"}**).

![**Inducible targeting of short and long BDNF 3′ UTR chimeric mRNAs.** ISH on hippocampal neurons transfected with either GFP-3′ UTR short **(A)** or long **(D)** in unstimulated (control) and stimulated conditions. **(D)** Central panel, control ISH using GFP sense probe on transfected cells. Arrows indicate MDDL (MDDL); scale bar 10 μm. MDDL quantification of BDNF 3′ UTR short **(B)** or BDNF 3′ UTR long **(E)** following KCl (10 mM) and neurotrophins (50 ng/ml) treatments, alone or in combination with the Trk inhibitor K252a (30 nM). Densitometric analysis of *GFP* mRNA distribution along dendrite length (0--110 μm) in neurons transfected with GFP-3′ UTR short **(C)** or long **(F)**, in resting conditions of after treatment with KCl, NT-3 or BDNF (^∗∗∗^*P* \< 0.001 vs. control, Kruskal--Wallis one way ANOVA on Ranks followed by Dunn's multiple comparison test).](fnmol-08-00062-g002){#F2}

Localization of the GFP-3′ UTR long chimera did not differ significantly from the GFP reporter alone in unstimulated cultures (MDDL = 43.14 ± 1.36 μm). However, depolarization induced strong accumulation of this mRNA in distal dendrites (MDDL = 62.44 ± 1.44 μm, *P* \< 0.001), similarly to the short 3′ UTR constructs (**Figures [2D,E](#F2){ref-type="fig"}**). Furthermore, application of 50 ng/ml BDNF (but not NT-3, NT-4 nor NGF) induced dendritic translocation of the GFP-3′ UTR long at distances comparable those induced by KCl depolarization (MDDL = 61.38 ± 1.92 μm). K252a application abolished BDNF-induced, and significantly reduced KCl-dependent, 3′ UTR long mRNA distal targeting, suggesting that BDNF signaling is required to enhance the depolarization effect on mRNA localization (**Figure [2E](#F2){ref-type="fig"}**). The ISH signals from the very same neurons were quantified by densitometric analysis throughout the entire dendritic length, leading to results comparable to those obtained with MDDL measurements (**Figures [2C,F](#F2){ref-type="fig"}**). Taken together, these results provide clear evidence that both the long and short 3′ UTR sequences are involved in inducible dendritic localization of *BDNF* mRNA. Dendritic targeting of *BDNF* mRNA is modulated by neuronal depolarization (KCl) for both regions but is specifically regulated by NT-3 for the short 3′ UTR and by BDNF for the long 3′ UTR.

Activity-dependent Dendritic Targeting of *BDNF* Short 3′ UTR mRNA *In vivo*
----------------------------------------------------------------------------

A previous study suggested that BDNF transcripts of BDNF^lox/lox^ mice, lacking a functional long 3′ UTR, are confined in the soma *in vivo* ([@B4]). However, activity-dependent targeting *in vivo* of short 3′ UTR transcript was not evaluated. To determine whether the short 3′ UTR form is targeted to dendrites also *in vivo*, we took advantage of the same BDNF^lox/lox^ mouse model ([@B20]). In WT mice in resting conditions, *BDNF* mRNA was detected in the soma and in the proximal dendrites of CA1 and CA3 neurons while in BDNF^lox/lox^ mice it was detectable only in the soma, as previously described ([@B4]; **Figure [3A](#F3){ref-type="fig"}**). However, after treatment with the pro-epileptic drug pilocarpine for 3 h, localization of *BDNF* transcripts in dendrites was observed both in WT and BDNF^lox/lox^ hippocampi, confirming the finding that *BDNF* mRNA splice variants with a short 3′ UTR can be transported in dendrites after stimulation (**Figure [3A](#F3){ref-type="fig"}**). Interestingly, in BDNF^lox/lox^ neurons a punctate distribution of BDNF mRNA was observed, whilst a more uniform signal was seen in WT animals. These differences may be due to the fact that the long 3′ UTR is lacking from distal compartments of BDNF^lox/lox^ neurons and therefore staining for *BDNF* mRNA is generally weaker. BDNF^lox/lox^ mice display decreased BDNF protein dendritic levels despite the total amount of protein is comparable ([@B4]). To test if pilocarpine treatment is able to increase BDNF protein levels in BDNF^lox/lox^ mice, brain sections from WT and mutated animals were immunostained with an anti-BDNF antibody. Hippocampal neurons of pilocarpine-treated WT and BDNF^lox/lox^ mice were found to display comparable labeling in distal dendrites (**Figure [3B](#F3){ref-type="fig"}**), providing further evidence that BDNF can reach distal dendrites even if it is translated from transcripts expressing the 3′ UTR short only.

![**Endogenous BDNF 3′ UTR short localization *in vivo*.** **(A)** Representative images of fluorescent *in situ* hybridization (FISH) of endogenous BDNF CDS in CA1 (upper panel) and CA3 (bottom panel) in wild type (WT) and BDNF^lox/lox^ transgenic mouse devoid of the long BDNF 3′ UTR sequence (lox) in basal conditions (left) and upon 3 h of pilocarpine-induced seizures (300 mg/kg, 3 h; right). Arrows indicate the maximal distance of dendritic labeling. **(B)** Representative images of BDNF protein immunostaining in CA1 area from the same brains used for FISH **(A)**; scale bar, 20 μm for **(A)** and 40 μm for **(B)**.](fnmol-08-00062-g003){#F3}

Multiple RNA Binding Proteins are Associated to *BDNF* mRNA
-----------------------------------------------------------

Previous evidence showed that *BDNF* mRNA trafficking and stabilization requires interaction with RBPs ([@B10]; [@B37]; [@B30]). To identify the RBPs interacting with the 3′ UTR short or long, we used an *in silico* approach to detect evolutionary conserved regions and putative binding proteins sites on each 3′ UTR variant. BDNF sequences were compared among primates, mammals, and vertebrates (see **Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**) using phast Cons alignment software ([@B52]). Several regions were found to be highly conserved (**Figure [4A](#F4){ref-type="fig"}**), with the short 3′ UTR region being the most conserved one, followed by the mid and terminal regions of the long 3′ UTR. To recognize binding motifs for RBPs, the bioinformatic analysis was focused on regions highly conserved among vertebrate species, which are more likely to share an evolutionary conserved biological function. We searched for consensus recognition sequences for some RBP families including cytoplasmatic polyadenylation element binding proteins (CPEBs), embryonic lethal abnormal vision like proteins (ELAVs) and Fragile X mental retardation protein (FMRP), which are known to bind to short, well-defined RNA sequences and are involved in RNA transport, translation, and stabilization. The short 3′ UTR (nts 1--321) displays one CPEB binding site and two different conserved sites for ELAV proteins (the upper 5′ site is referred here as to "ELAV up" and the 3′ most as "ELAV down"; **Figure [4B](#F4){ref-type="fig"}**). Additionally, in this region we found two other conserved sites, a Nanos response element (NRE) and a CUG rich region representing a potential target for Pumilio, a translational regulator ([@B62]), and for the CUG-binding protein (CUGBP), known to regulate splicing, deadenylation, mRNA stability and translation ([@B41]; [@B55]; [@B25]; [@B49]; [@B38]; [@B33]; [@B35]). Despite the high conservation degree of these sequences, we did not consider Pumilio and CUGBPs in the present study, since so far there are no clear reports assessing their involvement in regulation of mRNA transport. Even if the BDNF long 3′ UTR showed a higher degree of variability among species when compared to the short 3′ UTR, three conserved "hot spots" were identified (**Figures [4A,B](#F4){ref-type="fig"}**). The first conserved region, located at the boundary with the 3′ UTR short, presents an "ELAV rich region" with a cluster of binding sites for the ELAV-1 family member (HuR, red bars in **Figure [4B](#F4){ref-type="fig"}**). A nearby second conserved sequence, in the center of the long 3′ UTR, is characterized by a G-quartet like structure, known to be recognized by FMRP ([@B11]). Finally, a third region located at the end of the long 3′ UTR shows a pattern of *cis*-elements similar to the one found in the short 3′ UTR, with CPEs and ELAV recognition sites. Additionally, we found one BC1 ([@B47]) and several AU-rich response element (AURE), especially in the 3′ terminal region of the long 3′ UTR, which support a previously suggested possible involvement of hnRNPA2 RBP ([@B43]).

![**Brain-derived neurotrophic factor mRNA interaction with RNA binding proteins (RBPs).** **(A)** Graphical view of homology of BDNF coding regions and 3′ UTR among Primates, Mammals, and vertebrates. Similarity scores range from 0 (=no homology) to 1 (identical sequence). Numbers indicate the nucleotide position of BDNF gene on chromosome 11. **(B)** Putative binding sites for RBPs indicated with different colors at the corresponding positions along *BDNF* mRNA. Positions of the short 3′ UTR, long-mid 3′ UTR and long-end sequences used in UV-CLIP assays in **(C)** are also shown. (**C**, left panel) Reverse transcriptase-PCR of BDNF mRNA immunoprecipitated with an antibody against the neuronal ELAV proteins (IP-16A11), or a control IgG antibody (IP-IgG) or no antibody (IP-beads). Total brain RNA (Input) and no sample (Blank) were used as a positive and a negative control, respectively; (right panel) UV-CLIP assay with an anti-neuronal ELAV proteins antibody (IP-16a11) to immunoprecipitate RNA-protein complexes formed in presence of murine brain protein lysate and radiolabeled BDNF CDS, 3′ UTR short, or 3′ UTR long-mid and 3′ UTR long-end ribobrobes. As a negative control, UV-CLIP was performed using an anti-IgG antibody with a mix of all the *BDNF* riboprobes used. **(D)** Immunoblot assay to test specificity of the anti-FMRP antibody in inputs and immunoprecipitates from WT and Fmr1 knockout (KO) mice (left panel). Reverse transcriptase-PCR of *BDNF* mRNA recovered from immunoprecipitates from WT and *Fmr1* knockout lysates upon CLIP assay (middle panel). *Map1b*, a known mRNA target of FMRP protein, was used as a positive control, while *Pgk1*, an unrelated mRNA, as a negative control. Blank, no sample in Reverse transcriptase-PCR reaction. **(E)** Colocalization analysis of endogenous *BDNF* mRNA with different RBPs. Immunofluorescence signal from the different RBPs (green) and from endogenous *BDNF* mRNA (red) in proximal dendrites are shown separately (RBP, mRNA) and merged (MERGE). Images are Z-stack maximum projection of 12 stacks confocal images. Scale bar: 1 μm. **(F,G)** Graphs report the Manders coefficient (Y-axis) of RBPs signal colocalized with endogenous *BDNF* mRNA **(F)** and *BDNF* mRNA signal colocalized with the different RBP **(G)** in proximal (dark gray) and distal (light gray) dendrites. Data are reported as mean ± SEM. Statistical significance of proximal vs. distal Manders coefficients of colocalization was evaluated performing *t*-test if the normality test was passed, or Mann--Whitney Rank-Sum test (^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01; ^∗∗∗^*P* \< 0.001).](fnmol-08-00062-g004){#F4}

In order to detect an interaction of ELAVs with *BDNF* transcripts, we performed a RNA immunoprecipitation (RIP) assay on mouse brain lysates using a pan-neuronal ELAV (nELAV) antibody, followed by Reverse transcriptase-PCR. This analysis showed that *BDNF* mRNA was selectively recovered from anti-nELAV immunoprecipitates (IPs), but not from control-IgG IPs or in presence of beads alone (**Figure [4C](#F4){ref-type="fig"}**, left panel). To test the specificity of binding of nELAVs to the BDNF 3′ UTR sequence, we used radiolabeled riboprobes corresponding to BDNF short 3′ UTR and CDS in UV Cross-Linking Immunoprecipitation (UV-CLIP) assays with mouse brain protein lysates. In addition, we used two riboprobes corresponding to the central (mid, nts 890--1510) or terminal (end, nts 2339--2790) regions of the 3′ UTR long sequence that also contained ELAV consensus binding motifs (**Figures [4B,C](#F4){ref-type="fig"}**, right panel). No RNA-protein complex formed in presence of the CDS-specific riboprobe, whilst specific nELAV-*BDNF* RNA complexes were recovered in presence the short, mid and end 3′ UTR riboprobes (**Figure [4C](#F4){ref-type="fig"}**, right panel). To test for FMRP binding, we performed similar CLIP experiments with mouse brain lysates using a previously described polyclonal rabbit anti-FMRP antibody ([@B12]). The specificity of the anti-FMRP antibody used was first proven by immunoprecipitation assays using WT and *FMR1* knockout mouse brains as a negative control (**Figure [4D](#F4){ref-type="fig"}**, left). Accordingly, endogenous *BDNF* mRNA could be amplified via Reverse transcriptase-PCR from WT but not *FMR1* knockout mouse brains immunoprecipitates (**Figure [4D](#F4){ref-type="fig"}**, middle panel). *Map1b* and *Pgk1* mRNAs were used as positive and negative controls for FMRP binding, respectively (**Figure [4D](#F4){ref-type="fig"}**, right panel). Previous studies already demonstrated that CPEBs physically bind to BDNF CDS and 3′ UTR mRNA ([@B37]) and therefore the binding experiments for these proteins were not performed.

To verify if the above mentioned RBP are colocalized with BDNF mRNA in dendrites, we performed double labeling experiments with FISH against endogenous *BDNF* transcripts coupled to immunofluorescence (IF) for RBPs family members in unstimulated cultures (**Figure [4E](#F4){ref-type="fig"}**). Tyramide Amplification System was employed to visualize endogenous *BDNF* mRNA in distal dendrites, due to its intrinsic low abundance in such compartment of resting cultured neurons ([@B6]; [@B63]). The different RBPs taken in account in this study showed a similar distribution in dendrites, suggesting that they represent shared components of dendritic mRNA transporting granules. In proximal dendrites (**Figures [4E--G](#F4){ref-type="fig"}**), in unstimulated cultures, almost half of the staining spots of Translin, CPEB4, ELAV1, ELAV2, and FMRP were colocalized with endogenous *BDNF* mRNA (Manders coefficient 0.415 ± 0.041, 0,424 ± 0.036, 0.475 ± 0.040, 0.465 ± 0.028, and 0.485 ± 0.023, respectively), while other transporting granules were less colocalized, with Manders coefficient values ranging from 0.224 to 0.348. Similarly BDNF mRNA signal results to be more colocalized in the proximal compartment with Translin, ELAV1, ELAV2, ELAV3, and FMRP granules (Manders coefficient 0.417 ± 0.034, 0,420 ± 0.041, 0.440 ± 0.029, 0.444 ± 0.031, and 0.423 ± 0.024, respectively). In distal compartments more than half of the transporting granules stained for Translin were colocalized with *BDNF* mRNA (Manders coefficient 0.579 ± 0.035), while other RBPs display similar colocalization degree with RNA, except for the less colocalized ELAV3 and FXR2 (Manders coefficient 0.232 ± 0.026 and 0.240 ± 0.023, respectively). Moreover, *BDNF* mRNA displayed the highest colocalization rate with Translin protein (Manders coefficient 0.436 ± 0.032) confirming its involvement in this mRNA trafficking as previously demonstrated ([@B10]) while it showed a heterogeneous colocalization with other RBPs (Manders coefficient ranging from 0.152 to 0.304). CPEB-1 and ELAV-4 were undetectable after FISH, therefore they have been omitted in the colocalization analysis. Statistical comparison revealed that RBPs colocalization with BDNF mRNA was significantly higher in distal dendrites than in proximal dendrites for translin, CPEB2, CPEB3, while it was higher in proximal than in distal for ELAV3 and FMRP, and was equally distributed for CPEB4, ELAV1 and 2, and FXR2 (**Figure [4F](#F4){ref-type="fig"}**). Viceversa, when colocalization was analyzed taking BDNF mRNA as reference, we found that BDNF mRNA was significantly more localized with ELAV1, 2, 3, FMRP and FXR2 in proximal dendrites than in distal (**Figure [4G](#F4){ref-type="fig"}**), suggesting that this mRNA and these RBPs interact more in the initial segment of the dendrites.

Different Set of RBPs Regulates Long and Short 3′ UTRs Dendritic Targeting
--------------------------------------------------------------------------

To test if the identified RBPs contribute to the inducible mechanism of *BDNF* mRNA targeting to dendrites, dendritic localization of GFP-BDNF 3′ UTRs was measured following KCl, NT-3 or BDNF stimulation in neurons co-transfected with siRNA cocktails against each member of the CPEB, ELAV, or FRXP families. Analysis of siRNA efficacy showed a high degree of silencing of target RBPs (**Figures [5A,D](#F5){ref-type="fig"}** and **[6F](#F6){ref-type="fig"}**; **Supplementary Table [S4](#SM1){ref-type="supplementary-material"}**). The specificity of siRNAs used and the lack of off-target effects among homologous members of the CPEB and ELAV families were confirmed by Reverse transcriptase-PCR (**Figures [5A,D](#F5){ref-type="fig"}**; **Supplementary Table [S4](#SM1){ref-type="supplementary-material"}**). When considering the short BDNF 3′ UTR, both activity-dependent and NT-3 mediated localization of the reporter was found to require CPEB-1 and CPEB-2, but not CPEB-3 or CPEB-4 (CPEB-1 siRNA KCl MDDL = 37.16 ± 1.12 μm, CPEB-2 siRNA KCl MDDL = 37.48 ± 1.63 μm, ^∗∗∗∗^*P* \< 0.001 respect to KCl no siRNA; CPEB-1 siRNA NT-3MDDL = 37.69 ± 1.09 μm, CPEB-2 siRNA NT-3 MDDL = 38.96 ± 1.18 μm, ^\#\#\#^*P* \< 0.001 respect to NT-3 with no siRNA). A control siRNA against luciferase had no effect on *BDNF* mRNA targeting (**Figure [5B](#F5){ref-type="fig"}**, scramble). Disruption of the CPE binding site through site directed mutagenesis (UUUUAU to CGAUCG, **Figure [5C](#F5){ref-type="fig"}**) completely suppressed mRNA sorting in dendrites in response to extracellular stimuli, and further confirmed the role of CPEBs in *BDNF* mRNA trafficking ([@B22]). However, it is unclear whether CPEB 2 can bind directly to the mRNA, since UUUUAU is the consensus sequence for CPEB-1, and a specific CPEB-2 recognition site has not been described yet ([@B22]). Both ELAV-2 and ELAV-4 were required for KCl and NT-3-dependent transport of the 3′ UTR short (ELAV-2 siRNA KCl MDDL = 43.57 ± 1.99 μm, ELAV-4 siRNA NT-3 MDDL = 41.32 ± 1.39 μm, ^∗∗∗^*P* \< 0.001 respect to no siRNA KCl; ELAV-2 siRNA NT-3 MDDL = 42.53 ± 1.28 μm, ELAV-4 siRNA NT-3 MDDL = 41.48 ± 1.14 μm, ^∗∗∗^*P* \< 0.001 respect to no siRNANT-3; **Figures [5E,F](#F5){ref-type="fig"}**). The other two family members, ELAV-1 and -3, did not result involved in dendritic localization of BDNF 3′ UTR short. Involvement of ELAV-2 and-4 RBPs was further confirmed by the fact that disruption of either the 5′ or 3′ ELAV binding motifs (AUUUAU to AGCGCG) blocked BDNF 3′ UTR short dendritic targeting upon stimuli (**Figure [5F](#F5){ref-type="fig"}**). The relative RNA levels of these mutants were compared to the parental GFP and WT GFP 3′ UTR short mRNAs to rule out the possibility that the lack of dendritic localization of the 3′ UTR mutants could be related to a decreased stability or expression and indeed we did not observe any significant difference (**Supplementary Figures [S3A,B](#SM1){ref-type="supplementary-material"}**). In summary, these results clearly demonstrate that KCl and NT-3 are able to induce distal dendritic localization of BDNF 3′ UTR short through a complex post-transcriptional regulatory mechanism that requires the interaction of CPEB-1, CPEB-2, ELAV-2, and ELAV-4 RBPs.

![**Role of CPEB and ELAV proteins in BDNF 3′ UTR short activity-dependent targeting.** **(A,D)** Representative semiquantitative Reverse transcriptase-PCR for CPEBs (**A**, upper panel) and ELAVs (**D**, upper panel) expression levels in control neurons (CTRL), and in neurons silenced with siRNA specific for the indicated RBP or with a scramble siRNA (LUCIF) in comparison to those of total rat brain lysates, taken as positive control. GADPH expression level has been reported for normalization. Representative western blots on lysates from control (-) or silenced (+) PC12 cells with the CPEB (**A**, bottom panel) and ELAVs (**D**, bottom panel) -specific siRNAs. Tubulin was blotted for normalization. **(B)** MDDL quantification of ISH for GFP sequence on neurons transfected with GFP-3′ UTR short construct upon specific silencing of CPEB family members (1, 2, 3, 4) in presence of KCl (10 mM) or NT-3 (50 ng/ml). Controls are represented either by cells not treated with siRNAs or treated with a scramble siRNA (upper panel). **(C)** MDDL quantification of ISH for GFP sequence on neurons transfected with GFP-3′ UTR short construct WT and mutated in the CPEB binding site (upper panel). Representation of transcripts used for the experiments (bottom panel). **(E)** MDDL quantification of ISH for BDNF 3′ UTR short upon silencing of ELAV family members (1, 2, 3, 4) in presence of KCL (10 mM) or NT-3 (50 ng/ml) stimuli. Controls are represented either by cells not treated with siRNAs or treated with a scramble siRNA (upper and bottom panel). **(F)** MDDL quantification of ISH for BDNF 3′ UTR short WT or with mutated ELAV binding sites (upper panel). Representation of transcripts used for the experiments (bottom panel; ANOVA all vs. control with same treatment, ^∗∗∗^*P* \< 0.001; \#\#\#*P* \< 0.001).](fnmol-08-00062-g005){#F5}

![**Role of CPEBs, ELAVs, and FMRP proteins in *BDNF* 3′ UTR long activity-dependent targeting.** **(A--C)** MDDL quantification of ISH for GFP sequence on neurons transfected with GFP-3′ UTR long construct upon silencing of different RBPs (CPEB-1-4, **A**; ELAV-1-4, **B**; FMR1, FXR2, TRLN, hnRNPA2, **C**) in resting conditions or after KCl (10 mM) or BDNF (50 ng/ml) treatment. Controls are represented either by cells not treated with siRNAs or treated with a scramble siRNA (upper panel). **(D)** MDDL quantification of ISH for GFP sequence on neurons transfected with GFP-3′ UTR long construct containing full-length or final portion (nt 2339-end) of *BDNF* 3′ UTR long in resting conditions or after KCl (10 mM) or BDNF (50 ng/ml) treatment. **(E)** MDDL quantification of ISH for GFP sequence on neurons transfected with BDNF CDS-GFP and BDNF CDS-3′ UTR MID-GFP constructs, in resting conditions and after KCl (10 mM) or BDNF (50 ng/ml) treatment (left panel). Graphical representation of the constructs used for the experiments is reported in the bottom right panel (ANOVA all vs. control with same treatment, ^θθθ^*P* \< 0.001; ^∗∗∗^*P* \< 0.001; \#\#\#*P* \< 0.001). **(F)** Representative western blots on lysates from control (-) or silenced (+) PC12 cells with FMRP, FXR2, Translin, hnRNPA2/B1 specific siRNAs. Tubulin was blotted for normalization. **(G)** Schematic representation of GFP chimaeric transcripts.](fnmol-08-00062-g006){#F6}

A similar approach was used to identify key RBPs modulating the long BDNF 3′ UTR localization in distal dendrites upon KCl or BDNF stimuli. Dendritic targeting of the long isoform required CPEB-1 but not CPEB-2, CPEB-3, or CPEB-4 in both conditions (KCl MDDL = 48.84 ± 1.15 μm, ^∗∗∗^*P* \< 0.001 respect to no siRNA KCl, BDNF MDDL = 49.17 ± 1.55 μm, ^\#\#\#^*P* \< 0.001 respect to no siRNA BDNF; **Figure [6A](#F6){ref-type="fig"}**). Silencing of individual ELAV family members induced an unexpectedly complex pattern of responses. ELAV-1, -3, and -4 down-regulation promoted a significant increase in 3′ UTR long targeting after stimulation and even at resting conditions, in particular following silencing of ELAV-1 (ctrl MDDL = 59.90 ± 1.31 μm, ^θθθ^*P* \< 0.001 respect to ctrl no siRNA; KCl MDDL = 81.40 ± 1.64 μm, ^∗∗∗^*P* \< 0.001 respect to no siRNA KCl; BDNF MDDL = 78.36 ± 2.13 μm, ^\#\#\#^*P* \< 0.001 respect to no siRNA BDNF; **Figure [6B](#F6){ref-type="fig"}**). A similar increase in dendritic targeting of the 3′ UTR long was found at resting conditions also with siRNAs against the Fragile-X proteins (FXRPs) FMRP1 and FXR2, consistent with our recent study on total *BDNF* mRNA localization in *Fmr1^-/-^* mice ([@B30]; ^θθθ^*P* \< 0.001, **Figure [6C](#F6){ref-type="fig"}**). Interestingly, activity- or neurotrophin-induced dendritic targeting was normal in absence of FMRP or FXR2 (**Figure [6C](#F6){ref-type="fig"}**). Additionally, the role of other two RBPs, Translin and hnRNPA2/B1 was tested. Translin was used as an internal control since this protein does not appear to be involved in the sorting of 3′ UTR long while hnRNPA2/B was tested since putative AURE recognition elements have been identified in the terminal part of the 3′ UTR long. No significant alterations of BDNF 3′ UTR long mRNA targeting were observed after Translin or hnRNPA2/B1 silencing (**Figure [6C](#F6){ref-type="fig"}**). These findings suggest that a specific set of RBPs is able to retain 3′ UTR long-containing splice variants in the proximal dendritic compartment of resting neurons while other RBPs are involved in the dendritic targeting. These "soma-restrictive" proteins display clustered recognition sites in the 3′ UTR long central region which is remarkably well-conserved throughout the evolution (nts 890--1510, **Figure [4B](#F4){ref-type="fig"}**) while RBPs involved in the dendritic targeting appeared located mostly at the 3′ end of long 3′ UTR region (nts 2339--2790, **Figure [4B](#F4){ref-type="fig"}**).

The Long 3′ UTR Contains Two Distinct RNA Localization Signals with Opposing Functions
--------------------------------------------------------------------------------------

We speculated that the central region of the 3′ UTR long might contain a retention signal, able to counteract both the constitutive dendritic targeting signal in the coding region of *BDNF* mRNA ([@B10]) and the inducible signal present in the terminal part of the 3′ UTR long. To test this hypothesis, the terminal 3′ UTR long sequence (nts 2339--2790) was inserted at the 3′ of the GFP reporter (GFP-3′ UTR END, **Figure [6G](#F6){ref-type="fig"}**). This chimera displayed an increased distal targeting with respect to the full length 3′ UTR long under basal conditions (MDDL = 63.96 ± 1.93 μm, ^OOO^*P* \< 0.001 respect to ctrl 3′ UTR long), comparable to that observed when ELAV-1, -3, or -4 were silenced (compare **Figures [6D](#F6){ref-type="fig"}** and **[6B](#F6){ref-type="fig"}**). At the same time, both KCl and BDNF induced a small but significant increase in distal transport of the terminal 3′ UTR long sequence with respect to the full-length 3′ UTR long (3′ UTR END KCl MDDL = 73.41 ± 2.61 μm, ^∗∗∗^*P* \< 0.001 respect to KCl 3′ UTR long; 3′ UTR END BDNF MDDL = 75.79 ± 1.88 μm, ^\#\#\#^*P* \< 0.001 respect to BDNF 3′ UTR long, **Figure [6D](#F6){ref-type="fig"}**). To test the role of the central region of the 3′ UTR long, the sequence 849--1533 nt was cloned downstream the GFP reporter (GFP-3′ UTR MID, **Figure [6G](#F6){ref-type="fig"}**). The 3′ UTR MID fragment did not respond to any stimulus suggesting the absence of DTE while the CDS fragment was constitutively localized in dendrites (**Figure [6E](#F6){ref-type="fig"}**). However, when the central region was inserted at the 3′ end of the CDS-GFP construct (CDS-GFP-3'MID, **Figure [6G](#F6){ref-type="fig"}**; [@B10]), it completely suppressed the constitutive dendritic localization of the CDS (CDS-GFP-MID ctrl MDDL = 39.65 ± 0.91 μm vs. CDS-GFP ctrl MDDL = 57.25 ± 2.0 μm, ^θθθ^*P* \< 0.001, **Figure [6E](#F6){ref-type="fig"}**). Notably, this retention signal was relieved by BDNF (CDS-GFP-MID BDNF MDDL = 61.85 ± 1.63 μm), but not by stimulation with KCl (CDS-GFP-MID KCl MDDL = 45.17 ± 1.28 μm, ^∗∗∗^*P* \< 0.001 respect to KCl GFP-CDS, **Figure [6E](#F6){ref-type="fig"}**).

Discussion
==========

This study provides evidence of dendritic transport of both short and long *BDNF* 3′ UTR variants and unravels the core molecular mechanisms underlying inducible dendritic targeting of these two *BDNF* mRNA forms. A remarkable outcome of this study is the strikingly selective response to NT-3 for short 3′ UTR and to BDNF for long 3′ UTR. Activity- and NT3-dependent dendritic targeting of 3′ UTR short requires CPEB-1,2 and ELAV-2,4 while dendritic targeting of long 3′ UTR relies on a more complex mechanism. This includes BDNF-dependent release of soma-retention signals mediated by ELAV-1,3,4, FMRP and FXRP2, and KCl/BDNF-activation of inducible targeting signals mediated by CPEB-1.

We found that Neurotrophin-3 activates dendritic targeting of *BDNF* short 3′ UTR and BDNF activates the long 3′ UTR form. NT-3 was previously shown to be able to redistribute mRNAs to distal dendrites in cultured neurons but the mechanism has remained unknown ([@B24]). In addition, NT-3 is known to promote beta-actin mRNA localization within axonal growth cones through a mechanisms requiring blockade of microtubule depolymerisation following activation of cAMP-dependent protein kinase A (PKA; [@B64]). A remarkable finding of our study is that NT-3 can regulate the trafficking selected isoforms of BDNF. The reciprocal interplay between BDNF and NT-3 has been previously investigated *in vitro* and *in vivo* ([@B29]; [@B32]; [@B40]). BDNF and NT-3 have been shown to play counteracting effects in regulating cortical dendritic growth during development ([@B32]). Interestingly, the receptor for NT-3, TrkC, is the earliest neurotrophin receptor expressed during brain development, followed by a later expression of TrkB ([@B8]). Moreover, in visual cortex NT-3 mRNA levels, detected prenatally, dramatically decrease at later stages of development, with an opposing trend for BDNF mRNA ([@B27]; [@B40]). BDNF and NT-3, which act presumably by activating TrkB and TrkC receptors, coupled to activation of similar signaling mechanisms, have differential effects on dendritic targeting of BDNF mRNAs. Previous studies suggest, however, that mRNA dendritic transport activated by NT-3 or BDNF may be induced through different mechanisms which also govern protein translation at synapses ([@B26]). For instance, while it was previously shown that BDNF promotes the transport of its own mRNA along dendrites through a PI3K-dependent mechanism ([@B45]), NT-3 was shown to induce dendritic trafficking of beta-actin mRNA through a PKA-dependent mechanism ([@B64]).

There is a general consensus that BDNF mRNA levels in distal dendritic processes are low both under resting conditions and after stimulation *in vitro* and *in vivo* ([@B59], [@B58]; [@B4]; [@B63]). It has been proposed that *BDNF* mRNA is present in low amounts in dendrites, most likely because of a short half-life compared to other dendritic mRNAs ([@B63]) and it has been suggested that neuronal activity may selectively increase stability of the long 3′ UTR *BDNF* mRNA by interactions with the RBP ELAV-1/HuD ([@B17]; [@B3]). However, a previous study showed that *BDNF* short and long 3′ UTR variants are equally stabilized by activity ([@B17]) and interactions of ELAV-1/HuD with the short 3′ UTR were described ([@B28]). The lack of effect of KCl depolarization on *BDNF* mRNA decay in our conditions, suggests that its increase in dendrites is due to active transport rather than increased stability. Collectively, these previous studies and the results presented here, suggest that the most likely cause of the low levels of *BDNF* mRNA observed in distal dendrites is the result of a tight activity-dependent regulation of transport, which limits the quantity of *BDNF* mRNA available in dendrites.

Neither short nor long BDNF 3′ UTR mRNAs were found to require CPEB3 or CPEB4 for their dendritic localization. This is an interesting result, since both these CPEB-family members were shown to be required for synaptic plasticity and dendritic spine changes in Aplysia and mouse, through a prion-like mechanism which confers these proteins the ability to form dynamic aggregates ([@B16]), and which does not appear to be involved in BDNF mRNA trafficking. Another peculiar aspect of CPEB3 is that it has been recognized as self-cleaving ribozyme throughout the evolution ([@B48]), which may explain why we and others ([@B34]) found low cellular levels of this mRNA by PCR, in front of clearly detectable protein levels by western-blot and immunofluorescence.

We provide conclusive *in vitro* and *in vivo* evidence that *BDNF* transcripts with a short 3′ UTR can be targeted to dendrites in an activity-dependent manner by binding to CPEB-1, as previously suggested by two different laboratories ([@B37]; [@B7]). In addition, we show here that inducible dendritic targeting of the 3′ UTR short requires also ELAV-2 and -4. Interaction between the two ELAV sites on the short 3′ UTR may explain why the absence of either ELAV-2 or ELAV-4 leads to disruption of mRNA short targeting in dendrites. It has been suggested that ELAV-2-4 dimerization may allow the formation of RNA transporting granules able to interact with the cytoskeleton for transport and with the translational machinery ([@B18]; [@B5]). Moreover, we found one highly conserved CPEB-1 binding site also in the terminal part of long 3′ UTR, in close proximity to several motifs recognized by ELAV proteins; this region resulted to be a novel inducible DTE. Even if AU-rich binding sites were found in the long 3′ UTR, silencing of hnRNPA2/B1 did not affect long 3′ UTR mRNA trafficking most likely because of compensatory binding by hnRNP CBF-A (CArG Box binding Factor A), which was previously shown to be involved in BDNF mRNA trafficking ([@B43]). In the mid region of the long 3′ UTR, we identified a previously unknown retention signal able to overcome the constitutive dendritic targeting signal in the CDS mediated by Translin. These findings are in accordance with the observed increase in *BDNF* mRNA in dendrites of FMR1 knock-out mice under resting conditions ([@B30]) which might account for an increased susceptibility to epileptic seizures in these animals ([@B15]). Notably, FMR1 KO mice were found to have an exaggerated mTOR and PI3K activation ([@B51]). Since mRNA transport in dendrites can be mediated by PI3K ([@B45]), it is conceivable that the lack of targeting repression by FMRP and the enhanced PI3K signaling may provide a synergistic effect on *BDNF* mRNA transport. In contrast, the dynamics of short 3′ UTR localization seem to rely on the activation of dormant targeting elements and proteins, apparently without a soma-retention mechanism. Interestingly, a similar organization of targeting elements has been observed in CaMKIIα a prominent dendritically localized transcript. In fact, two opposing localization signals have been identified at the level of *CaMKIIα* 3′ UTR: a DTE in the first 28--56 nts of 3′ UTR, promoting RNA dendritic trafficking (also known as the CNDLE sequence), that is overridden by a downstream retention signal whose inhibition is relieved after KCl-induced depolarization ([@B36]). In *CaMKIIα* mRNA, two CPE elements in *CaMKIIα* 3′ UTR seem to facilitate mRNA transport and translational activation ([@B21]). In addition, it has been reported that the presence of a translin binding site at the level of the coding region, is necessary for transport of *CaMKIIα* mRNA in dendrites ([@B50]), as for *BDNF* mRNA. In *BDNF* 3′ UTR mRNA, we found AU-rich regions, ELAV binding sites and a G-quartet-like structure similar to CaMKIIα (for comparison, see [@B13]). Finally, *CaMKIIα* mRNA might be alternatively polyadenylated to generate a short or a long 3′ UTR, with the latter being much more abundant than the former. This striking parallelism between *BDNF* and *CaMKIIα cis* and *trans*-elements involved in their activity-dependent subcellular sorting further supports the "RNA operon theory" ([@B23]), by which common signals and RBPs are shared by different mRNAs with common functions (e.g., synaptic plasticity and potentiation).

The results shown here, together with previous findings from our laboratory, provide strong evidence that *BDNF* mRNAs display both activity-dependence and transcript selectivity. Transcript selectivity is mediated by signals located in the 5′ UTRs that for some variants may be either permissive to distal dendritic targeting or, in other variants, may promote mRNA retention in the soma/proximal dendrites by overriding localization signals harbored in the CDS and 3′ UTRs ([@B10]). These findings, together with the role of both 3′ UTRs in activity-dependent dendritic localization, as shown here, strongly argue in favor of a mechanism of BDNF mRNA subcellular sorting regulated by a tripartite signal (5′ UTRs = selectors, CDS = constitutive DTE, and 3′ UTRs = inducible DTE). In conclusion, we propose a model in which inducible dendritic targeting signals are harbored in both 3′ UTRs which respond selectively to different extracellular stimuli, thus proving the basis for a differential regulation of BDNF variants for the fine tuning of distal dendritic compartment plasticity.
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